DUALITY BIOTHERAPEUTICS, INC. - B
(HKEX: 9606)
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
336.000 -
-6.800
(-1.98%)
Range
329.800 - 344.000
(4.31%)
Open
340.200
Previous Close
342.800
Bid Price
335.800
Bid Volume
('000)
1.5
Ask Price
336.000
Ask Volume
('000)
0.5
Volume
('000)
575.6
Value
192,156,720
Remark
-
Delayed prices. Updated at 05 Dec 2025 14:54.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
